2023

Measures of attributes of locomotor capacity in older people:a systematic literature review following the COSMIN methodology

G. Honvo, S. Sabico, N. Veronese, O. Bruyère, R. Rizzoli, J. Amuthavalli Thiyagarajan, C. Mikton, T. Diaz, C. Cooper, J.-Y. Reginster

https://doi.org/10.1093/ageing/afad139
Sarcopenia, osteoporosis and frailty

E. Gielen, J. Dupont, M. Dejaeger, M. R. Laurent

https://doi.org/10.1016/j.metabol.2023.155638
Measuring health‐related quality of life in sarcopenia: summary of the SarQoL psychometric properties

C. Beaudart, J.‐Y. Reginster, J. Amuthavalli Thiyagarajan, I. Bautmans, J. Bauer, N. Burlet, M. Cesari, A. Cherubini, C. Cooper, A. J. Cruz‐Jentoft, B. Dawson‐Hughes, R. A. Fielding, N. C. Harvey, F. Landi, A. Laslop, S. Maggi, B. Montero‐Errasquin, P. Yerro María Concepción, Y. Rolland, R. Rizzoli, M. Visser, O. Bruyère

https://doi.org/10.1007/s40520-023-02438-3
Are inflammatory markers associated with sarcopenia-related traits in older adults with sarcopenia? – A cross-sectional analysis of the ENHANce study

J. Dupont, L. Vercauteren, N. Amini, L. Lapauw, M. De Schaepdryver, K. Poesen, L. Dedeyne, S. Verschueren, Jos Tournoy, K. Koppo, E. Gielen

https://doi.org/10.1016/j.exger.2023.112196
Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men

N. Amini, J. Dupont, L. Lapauw, L. Vercauteren, L. Antonio, T. W. O’Neill, D. Vanderschueren, N. Pendleton, G. Rastrelli, M. Maggi, F. F. Casanueva, J. Słowikowska-Hilczer, M. Punab, I. T. Huhtaniemi, F. C.W. Wu, S. Verschueren, J. Tournoy, E. Gielen

DOI: 10.1002/jcsm.13229
Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta-analysis

K. Prokopidis, P. Giannos, J.-Y. Reginster, O. Bruyere, M. Petrovic, A. Cherubini, K. K. Triantafyllidis, K. S. Kechagias, Y. Dionyssiotis,
M. Cesari, K. Ibrahim, D. Scott, M. Barbagallo, N. Veronese

DOI: 10.1002/jcsm.13190
Trial in Elderly with Musculoskeletal BMC Geriatrics Open Access Problems due to Underlying Sarcopenia— Faeces to Unravel the Gut and Inflammation Translationally (TEMPUS-FUGIT): protocol of a cross-sequential study to explore the gut-muscle axis in the d

L. Lapauw, J. Dupont, N. Amini, L. Vercauteren, S. Verschueren, J. Tournoy, J. Raes, E. Gielen

https://doi.org/10.1186/s12877-023-04291-5
Are dietary intake and nutritional status of specific polyunsaturated fatty acids correlated with sarcopenia outcomes in community-dwelling older adults with sarcopenia? – Exploratory results from ENHANce

J. Dupont, E. Wauters, L. Dedeyne, L. Vercauteren, N. Amini, L. Lapauw, C. Matthys, S. Verschueren, J. Tournoy, K. Koppo, E. Gielen0

https://doi.org/10.1186/s12877-023-04007-9

2022

Preliminary Evidence of Differential Expression of Myogenic and Stress Factors in Skeletal Muscle of Older Adults With Low Muscle Strength

S. Dalle, J. Dupont, L. Dedeyne, S. Verschueren, J. Tournoy, E. Gielen, K. Koppo

https://doi.org/10.1093/gerona/glac002
Resistance exercise in lean older adults: mind the gap in energy intake

S. Dalle, J. Dupont, E. Gielen, K. Koppo

https://doi.org/10.1017/S0007114521003093

2021

Physical Rehabilitation in Patients with Heart Failure

J. Dupont, K. Koppo, E. Gielen

DOI: 10.1056/NEJMc2113494
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)

J. Dupont, L. Antonio, L. Dedeyne, T. W. O’Neill, D. Vanderschueren, G. Rastrelli, M. Maggi, G. Bártfai, F. F. Casanueva, A. Giwercman, J. Słowikowska-Hilczer, M. Punab, I. T. Huhtaniemi, F. C.W. Wu, J. Tournoy, K. Koppo, E. Gielen

DOI: 10.1002/jcsm.12785
Personalized Protein Supplementation Improves Total Protein, Leucine, and Energy Intake in (Pre)Sarcopenic Community-Dwelling Older Adults in the ENHANce RCT

L. Dedeyne, J. Dupont, S. Verschueren, K. Koppo, J. Tournoy, C. Matthys, E. Gielen

doi: 10.3389/fnut.2021.672971

2020

Exercise and Nutrition for Healthy AgeiNg (ENHANce) project – effects and mechanisms of action of combined anabolic interventions to improve physical functioning in sarcopenic older adults: study protocol of a triple blinded, randomized controlled trial

L. Dedeyne, J. Dupont, K. Koppo, S. Verschueren, J. Tournoy, E. Gielen

https://doi.org/10.1186/s12877-020-01900-5
Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review

C. Beaudart, O. Bruyere, A. Geerinck, M. Hajaoui, A. Scafoglieri, S. Perkisas, I. Bautmans, E. Gielen, J.-Y. Reginster, F. Buckinx

https://doi.org/10.1016/j.clnesp.2019.09.012

2019

Influence of the new EWGSOP2 consensus definition on studies involving (pre)sarcopenic older persons. Com- ment on “Sarcopenia” by Tournadre et al. Joint Bone Spine

J. Dupont, L. Dedeyne, K. Koppo, S. Verschuren, J. Tournoy, E. Gielen

https://doi.org/10.1016/j.jbspin.2019.11.011
Malnutrition as a Strong Predictor of the Onset of Sarcopenia

C. Beaudart, D. Sanchez-Rodriguez, M. Locquet, J.-Y. Reginster, L. Lengelé, O. Bruyère

doi:10.3390/nu11122883
Prediction of Adverse Outcomes in Nursing Home Residents According to Intrinsic Capacity Proposed by the World Health Organization

A. Charles, F. Buckinx, M. Locquet, J.-Y. Reginster, J. Petermans, B. Gruslin, O. Bruyère

doi:10.1093/gerona/glz218
Myostatin: A Powerful Biomarker for Sarcopenia and Frailty?

M. R. Laurent, J. Dupont, M. Dejaeger, E. Gielen

DOI: 10.1159/000495839
The role of omega-3 in the prevention and treatment of sarcopenia

J. Dupont, L. Dedeyne, S. Dalle, K. Koppo, E. Gielen

https://doi.org/10.1007/s40520-019-01146-1
Age-related bone loss and sarcopenia in men

M. R. Laurent, L. Dedeyne, J. Dupont, B. Mellaerts, M. Dejaeger, E. Gielen

https://doi.org/10.1016/j.maturitas.2019.01.006

2018

The health economics burden of sarcopenia: a systematic review

O. Bruyère , C. Beaudart, O. Ethgen, J.-Y. Reginster, Médéa Locquet

https://doi.org/10.1016/j.maturitas.2018.11.003
Evaluation of the Responsiveness of the SarQoLÒ Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia

A. Geerinck, O. Bruyere, M. Locquet, J.-Y. Reginster, C. Beaudart

https://doi.org/10.1007/s12325-018-0820-z
Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia

A. Geerinck, A. Scheppers, C. Beaudart, O. Bruyère, W. Vandenbussche, R. Bautmans, S. Delye, I. Bautmans

J Musculoskelet Neuronal Interact 2018; 18(4):463-472
L’ÉVALUATION DE LA MASSE ET DE LA FORCE MUSCULAIRES EN PRATIQUE CLINIQUE

F. Buckinx, S. Baudry, I. Bautmans, C. Beaudart, J.-L. Croisier, E. Gielen, J.-F. Kaux, S. Perkisas, A. Scafoglieri2, O. Bruyère

ORTHO-RHUMATO | VOL 16 | N°2 | 2018

2017

Effects of multi-domain interventions in (pre)frail elderly on frailty, functional, and cognitive status: a systematic review

Dedeyne L.

Clinical Interventions in Aging 2017:12
Quality of life assessment in musculo-skeletal health

Beaudart C.

Aging Clin Exp Res DOI 10.1007/s40520-017-0794-8
Osteosarcopenia: where bone, muscle, and fat collide

Hirschfeld H. P.

Osteoporos Int DOI 10.1007/s00198-017-4151-8
Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review

Beaudart C.

Osteoporos Int (2017) 28:1817–1833 DOI 10.1007/s00198-017-3980-9
Minerals and Sarcopenia; The Role of Calcium, Iron, Magnesium, Phosphorus, Potassium, Selenium, Sodium, and Zinc on Muscle Mass, Muscle Strength, and Physical Performance in Older Adults: A Systematic Review

van Dronkelaar C. MSc

DOI: http://dx.doi.org/10.1016/j.jamda.2017.05.026
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

Beaudart C.

PLOS ONE | DOI:10.1371/journal.pone.0169548
Dose-response relationship between weekly resistance training volume and increases in muscle mass: A systematic review and meta-analysis

Schoenfelda B. J.

Journal of Sports Sciences, 35:11, 1073-1082, DOI: 10.1080/02640414.2016.1210197
A systematic review, meta-analysis and metaregression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults

Morton R. W.

Morton RW, et al. Br J Sports Med 2017;0:1–10. doi:10.1136/bjsports-2017-097608

2016

English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia

Beaudart C.

Age and Ageing 2016; 0: 1–7. doi: 10.1093/ageing/afw192
Sarcopenia in daily practice: assessment and management

Beaudart C. et al.

BMC Geriatr. 2016 Oct 5;16(1):170. DOI: 10.1186/s12877-016-0349-4
Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia

Beaudart C. et al.

Journal of Cachexia, Sarcopenia and Muscle (2016). DOI: 10.1002/jcsm.12149
quality of life questionnaire for Sarcopenia Beaudart C. et al. Journal of Cachexia, Sarcopenia and Muscle (2016). DOI: 10.1002/jcsm.12149 PDF icon Download Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia

Reginster J.-Y.

Aging Clin Exp Res (2016) 28:47–58 DOI 10.1007/s40520-015-0517-y
Effects of resistance training with moderate vs heavy loads on muscle mass and strength in the elderly: A meta-analysis

Csapo R.

Scand J Med Sci Sports 2016: 26: 995–1006 doi: 10.1111/sms.12536
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men

Gielen E. et al.

J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):242-52. doi: 10.1002/jcsm.12030. Epub 2015 Apr 27.

2015

Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia

Reginster J.-Y. et al.

Aging Clin Exp Res (2016) 28:47–58. DOI 10.1007/s40520-015-0517-y

2014

The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials

Beaudart C. et al.

J Clin Endocrinol Metab. 2014 Nov;99(11):4336-45. doi: 10.1210/jc.2014-1742. Epub 2014 Jul 17.
Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)

Cruz-Jentoft A. J. et al.

Age Ageing. 2014 Nov;43(6):748-59. doi: 10.1093/ageing/afu115. Epub 2014 Sep 21.
The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates

Studenski S. A. et al.

J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58. doi: 10.1093/gerona/glu010.

2013

Muscle size, strength and physical performance and their associations with bone structure in the Hertfordshire Cohort Study

Edwards M. H. et al.

J Bone Miner Res. 2013 November ; 28(11): 2295–2304. doi:10.1002/jbmr.1972.
Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group

Bauer J. et al.

J Am Med Dir Assoc. 2013 Aug;14(8):542-59. doi: 10.1016/j.jamda.2013.05.021. Epub 2013 Jul 16.

1998

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Cruz-Jentoft A. J. et al.

Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
Epidemiology of sarcopenia among the elderly in New Mexico

Baumgartner R. N. et al.

Am J Epidemiol. 1998 Apr 15;147(8):755-63.